These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36575175)

  • 1. Clinical recommendations for dry powder inhaler use in the management of COPD in primary care.
    Leving MT; Bosnic-Anticevich S; van Cooten J; de Sousa JC; Cvetkovski B; Dekhuijzen R; Dijk L; Pardo MG; Gardev A; Gawlik R; van der Ham I; Janse Y; Lavorini F; Maricoto T; Meijer J; Metz B; Price D; Roman-Rodriguez M; Schuttel K; Stoker N; Tsiligianni I; Usmani O; Emerson-Stadler R; Kocks JWH
    NPJ Prim Care Respir Med; 2022 Dec; 32(1):59. PubMed ID: 36575175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying critical inhalation technique errors in Dry Powder Inhaler use in patients with COPD based on the association with health status and exacerbations: findings from the multi-country cross-sectional observational PIFotal study.
    Kocks J; Bosnic-Anticevich S; van Cooten J; Correia de Sousa J; Cvetkovski B; Dekhuijzen R; Dijk L; Garcia Pardo M; Gardev A; Gawlik R; van der Ham I; Janse Y; Lavorini F; Maricoto T; Meijer J; Metz B; Price D; Roman Rodriguez M; Schuttel K; Stoker N; Tsiligianni I; Usmani O; Voorham J; Leving MT
    BMC Pulm Med; 2023 Aug; 23(1):302. PubMed ID: 37592263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers.
    W H Kocks J; Wouters H; Bosnic-Anticevich S; van Cooten J; Correia de Sousa J; Cvetkovski B; Dekhuijzen R; Dijk L; Dvortsin E; Garcia Pardo M; Gardev A; Gawlik R; van Geer-Postmus I; van der Ham I; Harbers M; de la Hoz A; Janse Y; Kerkhof M; Lavorini F; Maricoto T; Meijer J; Metz B; Price D; Roman-Rodriguez M; Schuttel K; Stoker N; Tsiligianni I; Usmani O; Leving MT
    NPJ Prim Care Respir Med; 2022 May; 32(1):18. PubMed ID: 35618739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs.
    Leving MT; van Boven JFM; Bosnic-Anticevich SZ; van Cooten J; Correia de Sousa J; Cvetkovski B; Dekhuijzen R; Dijk L; García Pardo M; Gardev A; Gawlik R; van der Ham I; Hartgers-Gubbels ES; Janse Y; Lavorini F; Maricoto T; Meijer J; Metz B; Price DB; Roman-Rodríguez M; Schuttel K; Stoker N; Tsiligianni I; Usmani OS; Kocks JH
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2401-2415. PubMed ID: 36185173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of PIF, Inhalation Technique and Medication Adherence on Health Status and Exacerbations in COPD: Protocol of a Real-World Observational Study (PIFotal COPD Study).
    Leving M; Wouters H; de la Hoz A; Bosnic-Anticevich S; Dekhuijzen R; Gardev A; Lavorini F; Meijer J; Price D; Rodríguez MR; Tsiligianni I; Usmani O; Wijnsma B; Kocks J
    Pulm Ther; 2021 Dec; 7(2):591-606. PubMed ID: 34533772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.
    Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P
    BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does mixing inhaler devices lead to unchecked inhaler technique errors in patients with COPD? Findings from the cross-sectional observational MISMATCH study.
    Dijk L; Kerkhof M; Driessen M; Gerritsma YH; Bosnic-Anticevich S; Correia-de-Sousa J; Dekhuijzen PNR; Leving M; Price DB; Tsiligianni I; Usmani O; Kerstjens HAM; Kocks JWH
    BMJ Open Respir Res; 2023 Dec; 10(1):. PubMed ID: 38135462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study.
    Mahler DA; Watz H; Emerson-Stadler R; Ritz J; Gardev A; Shaikh A; Drummond MB
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1729-1740. PubMed ID: 37599896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD.
    Jõgi R; Mattila L; Vahteristo M; Takala A; Lähelmä S; Vartiainen VA; Lindqvist A
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1193-1201. PubMed ID: 33958863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demystifying Dry Powder Inhaler Resistance with Relevance to Optimal Patient Care.
    Capstick TGD; Gudimetla S; Harris DS; Malone R; Usmani OS
    Clin Drug Investig; 2024 Feb; 44(2):109-114. PubMed ID: 38198116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
    Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dry Powder Inhalers: From Bench to Bedside.
    Chrystyn H; Azouz W; Tarsin W
    J Aerosol Med Pulm Drug Deliv; 2023 Dec; 36(6):324-335. PubMed ID: 38016124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FIDEPOC: Consensus on Inspiratory Flow and Lung Deposition as Key Decision Factors in COPD Inhaled Therapy.
    González-Torralba F; Baloira A; Abad A; Fuster A; García-Rivero JL; García-Sidro P; Márquez-Martín E; Palop M; Soler N; Velasco JL
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1005-1015. PubMed ID: 35547784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of real-life data on the use of inhaler devices, including satisfaction and adherence to treatment, by community pharmacists in partnership with pulmonary disease specialists.
    Gemicioglu B; Gungordu N; Can G; Alp Yıldırım FI; Uydeş Doğan BS
    J Asthma; 2023 Jul; 60(7):1326-1335. PubMed ID: 36332164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease.
    Loh CH; Ohar JA
    Curr Opin Pulm Med; 2024 Mar; 30(2):174-178. PubMed ID: 38164804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
    Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Use of Easyhaler
    Kainu A; Vartiainen VA; Mazur W; Hisinger-Mölkänen H; Lavorini F; Janson C; Andersson M
    Pulm Ther; 2024 Mar; 10(1):133-142. PubMed ID: 38170393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation.
    Price DB; Yang S; Ming SWY; Hardjojo A; Cabrera C; Papaioannou AI; Loukides S; Kritikos V; Bosnic-Anticevich SZ; Carter V; Dorinsky PM
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3937-3946. PubMed ID: 30587952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Study of Inhaler Device Handling Technique and Risk Factors for Critical Inhaler Errors in Korean COPD Patients.
    Jang JG; Chung JH; Shin KC; Jin HJ; Lee KH; Ahn JH
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1051-1059. PubMed ID: 33907392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.
    Svedsater H; Dale P; Garrill K; Walker R; Woepse MW
    BMC Pulm Med; 2013 Dec; 13():72. PubMed ID: 24314123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.